Bank Of New York Mellon Corp Zynerba Pharmaceuticals, Inc. Transaction History

Bank Of New York Mellon Corp

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.5 - $0.72 $18,331 - $26,396	36,662 New	36,662 $19,000
Q3 2022 Nov 14, 2022	BUY	$0.87 - $1.36 $87 - $136	100 Added 0.27%	36,743 $27,000
Q2 2022 Aug 15, 2022	SELL	$0.86 - $2.06 $60 - $144	-70 Reduced 0.19%	36,643 $42,000
Q3 2021 Nov 12, 2021	BUY	$3.72 - $5.35 $63,448 - $91,249	17,056 Added 86.77%	36,713 $156,000
Q2 2021 Aug 11, 2021	SELL	$3.83 - $5.98 $7,257 - $11,332	-1,895 Reduced 8.79%	19,657 $0
Q1 2021 May 13, 2021	SELL	$3.33 - $8.76 $6,333 - $16,661	-1,902 Reduced 8.11%	21,552 $0
Q4 2020 Feb 09, 2021	BUY	$3.27 - $4.64 $43,451 - $61,656	13,288 Added 130.71%	23,454 $0
Q3 2020 Nov 12, 2020	BUY	$3.23 - $4.3 $3 - $4	1 Added 0.01%	10,166 $0
Q2 2020 Aug 12, 2020	SELL	$3.31 - $6.54 $176,389 - $348,516	-53,290 Reduced 83.98%	10,165 $0
Q1 2020 May 06, 2020	SELL	$2.9 - $6.16 $13,183 - $28,003	-4,546 Reduced 6.69%	63,455 $0
Q4 2019 Feb 14, 2020	BUY	$5.61 - $8.57 $36,711 - $56,082	6,544 Added 10.65%	68,001 $0
Q3 2019 Nov 07, 2019	BUY	$7.56 - $15.44 $23,882 - $48,774	3,159 Added 5.42%	61,457 $0
Q2 2019 Aug 12, 2019	BUY	$5.4 - $15.5 $314,809 - $903,619	58,298 New	58,298 $789,000
Q2 2018 Aug 06, 2018	SELL	$7.98 - $12.39 $265,885 - $412,822	-33,319 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$8.49 - $13.46 $12,768 - $20,243	1,504 Added 4.73%	33,319 $290,000
Q4 2017 Feb 09, 2018	BUY	$8.69 - $14.59 $276,472 - $464,180	31,815	31,815 $398,000

774K

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.